These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

148 related articles for article (PubMed ID: 22868390)

  • 21. Plasma globotriaosylsphingosine as a biomarker of Fabry disease.
    Togawa T; Kodama T; Suzuki T; Sugawara K; Tsukimura T; Ohashi T; Ishige N; Suzuki K; Kitagawa T; Sakuraba H
    Mol Genet Metab; 2010 Jul; 100(3):257-61. PubMed ID: 20409739
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Long-term changes in arterial structure and function and left ventricular geometry after enzyme replacement therapy in patients affected with Fabry disease.
    Collin C; Briet M; Tran TC; Beaussier H; Benistan K; Bensalah M; Mousseaux E; Froissart M; Bozec E; Laurent S; Boutouyrie P; Germain DP
    Eur J Prev Cardiol; 2012 Feb; 19(1):43-54. PubMed ID: 21450622
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [Prognostic value of brachial artery flow--mediated dilation and carotid artery intima-media thickness in hypertensive patients].
    Savoiu G; Drăgan S; Nicola T; Fira-Mladinescu O; Gorun C; Noveanu L; Tudor A; Muntean D; Mihalas G
    Rev Med Chir Soc Med Nat Iasi; 2008; 112(2):331-6. PubMed ID: 19295000
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Amelioration of serum 8-OHdG level by enzyme replacement therapy in patients with Fabry cardiomyopathy.
    Chen KH; Chou YC; Hsiao CY; Chien Y; Wang KL; Lai YH; Chang YL; Niu DM; Yu WC
    Biochem Biophys Res Commun; 2017 Apr; 486(2):293-299. PubMed ID: 28300554
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Plasma LysoGb3: A useful biomarker for the diagnosis and treatment of Fabry disease heterozygotes.
    Nowak A; Mechtler TP; Desnick RJ; Kasper DC
    Mol Genet Metab; 2017; 120(1-2):57-61. PubMed ID: 27773586
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Consequences of a global enzyme shortage of agalsidase beta in adult Dutch Fabry patients.
    Smid BE; Rombach SM; Aerts JM; Kuiper S; Mirzaian M; Overkleeft HS; Poorthuis BJ; Hollak CE; Groener JE; Linthorst GE
    Orphanet J Rare Dis; 2011 Oct; 6():69. PubMed ID: 22041095
    [TBL] [Abstract][Full Text] [Related]  

  • 27. α-Galactosidase A/lysoGb3 ratio as a potential marker for Fabry disease in females.
    Baydakova GV; Ilyushkina AA; Moiseev S; Bychkov IO; Nikitina NV; Buruleva ТА; Zakharova EY
    Clin Chim Acta; 2020 Feb; 501():27-32. PubMed ID: 31770509
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Screening for Fabry Disease in Japanese Patients with Young-Onset Stroke by Measuring α-Galactosidase A and Globotriaosylsphingosine.
    Kinoshita N; Hosomi N; Matsushima H; Nakamori M; Yagita Y; Yamawaki T; Torii T; Kitamura T; Sueda Y; Shimomura R; Araki M; Nezu T; Aoki S; Ishii S; Maruyama H; Matsumoto M; Maruyama H
    J Stroke Cerebrovasc Dis; 2018 Dec; 27(12):3563-3569. PubMed ID: 30201457
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Flow-mediated vasodilatation of the brachial artery and intima-media thickness of carotid artery in never-treated subjects.
    Irace C; Fiaschi E; Cortese C; Gnasso A
    Int Angiol; 2006 Sep; 25(3):274-9. PubMed ID: 16878076
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Screening of male dialysis patients for fabry disease by plasma globotriaosylsphingosine.
    Maruyama H; Takata T; Tsubata Y; Tazawa R; Goto K; Tohyama J; Narita I; Yoshioka H; Ishii S
    Clin J Am Soc Nephrol; 2013 Apr; 8(4):629-36. PubMed ID: 23307880
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Intrafamilial correlations of carotid intima-media thickness and flow-mediated dilation in a Siberian population.
    Ryabikov A; Malyutina S; Ryabikov M; Kuznetsova T; Staessen JA; Nikitin Y
    Am J Hypertens; 2007 Mar; 20(3):248-54. PubMed ID: 17324734
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Intima-media thickness of brachial artery, vascular function, and cardiovascular risk factors.
    Iwamoto Y; Maruhashi T; Fujii Y; Idei N; Fujimura N; Mikami S; Kajikawa M; Matsumoto T; Kihara Y; Chayama K; Noma K; Nakashima A; Higashi Y
    Arterioscler Thromb Vasc Biol; 2012 Sep; 32(9):2295-303. PubMed ID: 22796580
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Carotid intima-media thickness and brachial-ankle pulse wave velocity in patients with and without coronary artery disease.
    Kasliwal RR; Bansal M; Bhargava K; Gupta H; Tandon S; Agrawal V
    Indian Heart J; 2004; 56(2):117-22. PubMed ID: 15377132
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Endothelial dysfunction, intima-media thickness and coronary reserve in relation to risk factors and Framingham score in patients without clinical atherosclerosis.
    Campuzano R; Moya JL; García-Lledó A; Tomas JP; Ruiz S; Megías A; Balaguer J; Asín E
    J Hypertens; 2006 Aug; 24(8):1581-8. PubMed ID: 16877961
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Plasma Globotriaosylsphingosine and α-Galactosidase A Activity as a Combined Screening Biomarker for Fabry Disease in a Large Japanese Cohort.
    Maruyama H; Taguchi A; Mikame M; Izawa A; Morito N; Izaki K; Seto T; Onishi A; Sugiyama H; Sakai N; Yamabe K; Yokoyama Y; Yamashita S; Satoh H; Toyoda S; Hosojima M; Ito Y; Tazawa R; Ishii S
    Curr Issues Mol Biol; 2021 Jun; 43(1):389-404. PubMed ID: 34205365
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Increased carotid intima-media thickness in the absence of atherosclerotic plaques in an adult population with Fabry disease.
    Barbey F; Brakch N; Linhart A; Jeanrenaud X; Palecek T; Bultas J; Burnier M; Hayoz D
    Acta Paediatr Suppl; 2006 Apr; 95(451):63-8. PubMed ID: 16720468
    [TBL] [Abstract][Full Text] [Related]  

  • 37. The effect of low-dose combined oral contraceptive pills on brachial artery endothelial function and common carotid artery intima-media thickness.
    Heidarzadeh Z; Asadi B; Saadatnia M; Ghorbani A; Fatehi F
    J Stroke Cerebrovasc Dis; 2014 Apr; 23(4):675-80. PubMed ID: 23834851
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Multicenter evaluation of use of dried blood spot compared to conventional plasma in measurements of globotriaosylsphingosine (LysoGb3) concentration in 104 Fabry patients.
    Malvagia S; Ferri L; Della Bona M; Borsini W; Cirami CL; Dervishi E; Feriozzi S; Gasperini S; Motta S; Mignani R; Trezzi B; Pieruzzi F; Morrone A; Daniotti M; Donati MA; la Marca G
    Clin Chem Lab Med; 2021 Aug; 59(9):1516-1526. PubMed ID: 33915609
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Low serum bilirubin levels are independently and inversely related to impaired flow-mediated vasodilation and increased carotid intima-media thickness in both men and women.
    Erdogan D; Gullu H; Yildirim E; Tok D; Kirbas I; Ciftci O; Baycan ST; Muderrisoglu H
    Atherosclerosis; 2006 Feb; 184(2):431-7. PubMed ID: 15979081
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Combined assessment of flow-mediated dilation of the brachial artery and brachial-ankle pulse wave velocity improves the prediction of future coronary events in patients with chronic coronary artery disease.
    Sugamata W; Nakamura T; Uematsu M; Kitta Y; Fujioka D; Saito Y; Kawabata K; Obata JE; Watanabe Y; Watanabe K; Kugiyama K
    J Cardiol; 2014 Sep; 64(3):179-84. PubMed ID: 24556367
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.